Tumor-Targeted In Situ Immunization; Off-The Shelf & Systemically-Administered

Time: 8:30 am


• Re-assessing the role of cytotoxins as stimulators of immunogenic cell death in propogating more robust immune response
• Targeted immunostimulators generate innate immune responses to tumors while increasing systemic tolerability
• Homogeneous combination conjugates of mechanistically different payloads to an antibody opens up systemically administered “in situ immunisation”